8月5日，Liquidia Technologies盘中上涨5.41%，报88.475美元/股，成交额3513.56万美元。
Liquidia Technologies所在的制药行业中，个股中，礼来涨0.49%，辉瑞涨2.18%，阿斯利康跌0.16%，强生跌0.76%，默沙东涨0.74%。
Liquidia Corporation是一家生物制药公司，专注于解决未满足患者需求产品的开发、制造和商业化，目前的重点是肺动脉高压的治疗。其核心产品YUTREPIA（曲前列尼尔吸入粉）一季度净产品销售额约1.3亿美元，当季EPS为0.52美元，公司下一次财报预计于8月12日发布，市场预期EPS为0.70美元。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.